| 000 | 01781 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250513120258.0 | ||
| 264 | 0 | _c19970619 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenslee-Downey, P J | |
| 245 | 0 | 0 |
_aUse of partially mismatched related donors extends access to allogeneic marrow transplant. _h[electronic resource] |
| 260 |
_bBlood _cMay 1997 |
||
| 300 |
_a3864-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnemia, Aplastic _xmortality |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xepidemiology |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xmortality |
| 650 | 0 | 4 | _aHistocompatibility |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xmortality |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aAbhyankar, S H | |
| 700 | 1 | _aParrish, R S | |
| 700 | 1 | _aPati, A R | |
| 700 | 1 | _aGodder, K T | |
| 700 | 1 | _aNeglia, W J | |
| 700 | 1 | _aGoon-Johnson, K S | |
| 700 | 1 | _aGeier, S S | |
| 700 | 1 | _aLee, C G | |
| 700 | 1 | _aGee, A P | |
| 773 | 0 |
_tBlood _gvol. 89 _gno. 10 _gp. 3864-72 |
|
| 999 |
_c9141934 _d9141934 |
||